The VIADUCT - Issue 8
Issue 8 - Spring 2025 In this issue: From the Registry Director • Cholangiocarcinoma (CCA) Survey • WIND-PSC Enrolling Patients •...
Chemomab Announces Results from Open Label Extension of SPRING Trial for Nebokitug (CM-101) in PSC
Today, March 27, 2025, Chemomab Therapeutics issued a press release announcing results from the Open Label Extension (OLE) section of the...
External Survey on PSC and Quality of Healthcare
A new survey outside the Registry that focuses on understanding and improving the care of people living with PSC is now available. Every...